New full dopamine D3 receptor agonist CJ-1639 displays potent and selective activity in vivo July 11, 2011 No Comments
Titan Pharmaceuticals to begin unblinding and data analysis for confirmatory Probuphine trial July 7, 2011 No Comments
ALXN-4100TPO counteracts effects of radiation by inducing hematopoietic recovery in vivo July 1, 2011 No Comments
Lundbeck completes final trial of phase III nalmefene program in alcohol dependence June 15, 2011 No Comments
Cleveland BioLabs and BARDA advance negotiations relating to development of CBLB-502 June 1, 2011 No Comments
DM-CocE protects against and reverses acute cocaine toxicity in rats and primates May 17, 2011 No Comments
RSS